Nezam El-Tayebat Fact CheckA scientific assessment of the “نظام الطيبات” nutrition system
Choose country

Mostly true Certainty of evidence: high provisional C-BAR-09

Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.

Conclusion: Correct number, but surgery narrowed the gap rather than causing it.
  1. Original statement
  2. Scientific assessment
  3. In plain language
  4. Studies on this claim
  5. Regional context
  6. What applies in my country?
  7. References

Original statement

حتى أكبر تجربة طويلة الأمد (SOS) أظهرت أن مرضى الجراحة يموتون قبل عامة السكان بـ 5.5 سنوات.

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.

Origin

Source status
Archive editors
Attribution
Archive editors (eltayebat.com); not necessarily Elawady's own words
Origin
https://eltayebat.com/rule/bariatric-surgery/
Attribution uncertainty
Editorial summary/narrative and study selection written by the archive operators; the archive states that the cited research documents harm independently of Dr. Diaa's words.
Claimed mechanism

Implied: surgery does not restore normal survival.

Claimed health effect

Shorter life than general population.

Population concerned

SOS participants

Geographic restriction by Elawady

not applicable

Scientific assessment

Mostly true – Correct at its core, but with limitations or minor inaccuracies.

Certainty of evidence: high – Further research is very unlikely to change the assessment.

1. What was claimed?

SOS patients die 5.5 years earlier than the general population.

2. What is demonstrably correct?

Correct: adjusted median life expectancy in the surgery group was 5.5 years shorter than in the general population, and 3.0 years longer than in usual care (A-BAR-05).

3. What is wrong or exaggerated?

Read alone, the summary suggests surgery shortens life. The full text shows the non-operated obesity group had an 8.5-year shorter life expectancy; surgery reduced the gap. The authors attribute the remaining gap to persistent above-normal BMI, irreversible metabolic damage, surgical complications and other causes (alcoholism, suicide, trauma).

4. What remains unclear?

Whether modern procedures narrow the gap more.

5. Which studies support it?

A-BAR-05.

6. Which studies contradict it?

A-BAR-05 (full context), I-BAR-01, I-BAR-10.

7. What applies to Germany and Europe?

Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.

8. What is known about Egypt?

No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.

9. What practical conclusion is appropriate?

Bariatric surgery improves but does not normalize life expectancy in severe obesity.

Assessment details

Rationale for certainty of evidence

Number directly reported in the NEJM abstract and full text; interpretation issue only.

Source quality

The number is correct. The summary omits that controls lived about 8.5 years less than the general population, so surgery narrowed the gap by 3 years; SOS is a non-randomized controlled study, not a randomized 'trial'. The narrative and featured card report both numbers correctly.

Regional transferability

Swedish data.

Individual exceptions

Not applicable.

Regional scope of the claim
general (biological/medical)
Last reviewed
25 October 2026 provisional

In plain language

The archive says that even after surgery, Swedish patients died about 5.5 years earlier than the general population. The number is correct. But the same study shows that people with obesity who did not have surgery lived about 8.5 years less than the general population. Surgery therefore added about 3 years of life; it did not cause the remaining gap. Severe obesity itself shortens life.

Studies on this claim

Studies supporting the claim (1)

  • Swedish 24-year study: surgery added about 3 years of life

    Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449
    Cohort studycited by the Tayebat archivefull text checked★ key study

    Operated patients lived about 3 years longer than non-operated patients with obesity, but still about 5.5 years less than the general population (non-operated: about 8.5 years less).

    Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Life expectancy

    How was the study done?

    Prospective controlled cohort with population reference

    How many people, animals or samples were studied?

    5182 people

    What was actually found?

    Surgery gained 3 years; gap to population 5.5 vs 8.5 years

    How large was the observed effect?

    HR death 0.77; +3.0 years

    What do the results mean in everyday life?

    Surgery reduced but did not remove the life-expectancy loss linked to severe obesity

    What are the study's limitations?

    Not randomized; old operations

    What does it say about Elawady's specific claim?

    Number correct, implication 'surgery shortens life' wrong

    Do the results apply to Germany and Europe?

    Directly European

    What can explicitly not be concluded from this study?

    That surgery causes the remaining 5.5-year gap

    Scientific details →

Studies contradicting or limiting the claim (2)

  • Meta-analysis: weight-loss surgery and survival

    Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2
    Meta-analysisindependent cross-checkabstract only checked★ key study

    Across 174,772 people, surgery was linked to about half the risk of death and about 6 more years of median life expectancy; sleeve showed similar effects to bypass.

    Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Survival

    How was the study done?

    Meta-analysis of matched cohorts

    How many people, animals or samples were studied?

    174,772

    What was actually found?

    Lower mortality

    How large was the observed effect?

    HR ~0.51; +6.1 years

    What do the results mean in everyday life?

    Surgery is linked to longer, not shorter, life in severe obesity

    What are the study's limitations?

    Observational studies

    What does it say about Elawady's specific claim?

    Contradicts 'lethal'

    Do the results apply to Germany and Europe?

    Includes Europe

    What can explicitly not be concluded from this study?

    Exact causal size

    Scientific details →

  • Body weight and death risk worldwide

    Global BMI Mortality Collaboration. Lancet 2016 · PMID 27423262 · DOI 10.1016/S0140-6736(16)30175-1
    Meta-analysisindependent cross-checkfull text checked

    Severe obesity (BMI 40+) was linked to nearly 3 times the death risk of normal weight.

    Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    BMI-mortality

    How was the study done?

    IPD meta-analysis

    How many people, animals or samples were studied?

    ~4 million

    What was actually found?

    Higher BMI, higher mortality

    How large was the observed effect?

    HR 2.76 grade 3

    What do the results mean in everyday life?

    Severe obesity itself shortens life

    What are the study's limitations?

    Observational

    What does it say about Elawady's specific claim?

    Context for SOS gap

    Do the results apply to Germany and Europe?

    Includes Europe

    What can explicitly not be concluded from this study?

    Effect of weight loss

    Scientific details →

Studies with mixed or unclear results (0)

No studies in this group.

Regional context

Germany / EU

Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.

Egypt

No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.

What applies in my country?

General scientific assessment

Mostly true Correct number, but surgery narrowed the gap rather than causing it.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

  1. Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study.. Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449
  2. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.. Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2
  3. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.. Global BMI Mortality Collaboration. Lancet 2016 · PMID 27423262 · DOI 10.1016/S0140-6736(16)30175-1

← Back to overview